A Multicenter, Clinical Study of FOLFOXIRI With Bevacizumab As First-line Therapy in Patients With mCRC
Clinical trial NCT02246049 · COMPLETED
Trial details
- NCT number
- NCT02246049
- Sponsor
- EPS Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2017-02-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.